Should We Consider UGT1A1 Mutation Analysis in Evaluating the Prolonged Jaundice of Newborn Infants?

키워드

참고문헌 (53)

1. Logan S, "Screening for biliary atresia", Lancet, 342, pp.256~ (1993)
2. McKiernan PJ, "Neonatal cholestasis", Semin Neonatol, 7, pp.153~165 (2002)
3. Lee WS, "Disease of the liver and biliary system in children", pp.35~41 (2017), Wiley-Blackwell
4. Guillemette C, "Pharmacogenomics of human UDP-glucuronosyltransferase enzymes", Pharmacogenomics J, 3, pp.136~158 (2003)
5. Mackenzie PI, "The UDP glycosyltransferase gene superfamily : recommended nomenclature update based on evolutionary divergence", Pharmacogenetics, 7, pp.255~269 (1997)
6. Bosma PJ, "Sequence of exons and the flanking regions of human bilirubin-UDP-glucuronosyltransferase gene complex and identification of a genetic mutation in a patient with Crigler-Najjar syndrome, type I", Hepatology, 15, pp.941~947 (1992)
7. Bosma PJ, "Bilirubin UDP-glucuronosyltransferase 1is the only relevant bilirubin glucuronidating isoform in man", J Biol Chem, 269, pp.17960~17964 (1994)
8. Bosma PJ, "The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert’s syndrome", N Engl J Med, 333, pp.1171~1175 (1995)
9. Monaghan G, "Genetic variation in bilirubin UPD-glucuronosyltransferase gene promoter and Gilbert’s syndrome", Lancet, 347, pp.578~581 (1996)
10. Monaghan G, "Gilbert’s syndrome is a contributory factor in prolonged unconjugated hyperbilirubinemia of the newborn", J Pediatr, 134, pp.441~446 (1999)
11. Kaplan M, "Bilirubin genetics for the nongeneticist : hereditary defects of neonatal bilirubin conjugation", Pediatrics, 111(4 Pt 1), pp.886~893 (2003)
12. Ritter JK, "Identification of a genetic alteration in the code for bilirubin UDP-glucuronosyltransferase in the UGT1 gene complex of a Crigler-Najjar type I patient", J Clin Invest, 90, pp.150~155 (1992)
13. Crigler JF Jr, "Congenital familial nonhemolytic jaundice with kernicterus", Pediatrics, 10, pp.169~180 (1952)
14. Moghrabi N, "Identification of an A-to-G missense mutation in exon 2 of the UGT1 gene complex that causes Crigler-Najjar syndrome type 2", Genomics, 18, pp.171~173 (1993)
15. Strassburg CP, "Pharmacogenetics of Gilbert’s syndrome", Pharmacogenomics, 9, pp.703~715 (2008)
16. Burchell B, "Molecular genetic basis of Gilbert’s syndrome", J Gastroenterol Hepatol, 14, pp.960~966 (1999)
17. Owens D, "Population studies on Gilbert’s syndrome", J Med Genet, 12, pp.152~156 (1975)
18. Lampe JW, "UDP-glucuronosyltransferase(UGT1A1*28 and UGT1A6*2)polymorphisms in Caucasians and Asians : relationships to serum bilirubin concentrations", Pharmacogenetics, 9, pp.341~349 (1999)
19. Roy-Chowdhury N, "Presence of the genetic marker for Gilbert syndrome is associated with increased level and duration of neonatal jaundice", Acta Paediatr, 91, pp.100~101 (2002)
20. Liu W, "Genetic factors affecting gene transcription and catalytic activity of UDP-glucuronosyltransferases in human liver", Hum Mol Genet, 23, pp.5558~5569 (2014)
21. Shin HJ, "Functional study of haplotypes in UGT1A1 promoter to find a novel genetic variant leading to reduced gene expression", Ther Drug Monit, 37, pp.369~374 (2015)
22. Takeuchi K, "Genetic polymorphisms of bilirubin uridine diphosphateglucuronosyltransferase gene in Japanese patients with Crigler-Najjar syndrome or Gilbert’s syndrome as well as in healthy Japanese subjects", J Gastroenterol Hepatol, 19, pp.1023~1028 (2004)
23. Huang CS, "Variations of the bilirubin uridine-diphosphoglucuronosyl transferase 1A1 gene in healthy Taiwanese", Pharmacogenetics, 10, pp.539~544 (2000)
24. Kadakol A, "Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase(UGT1A1)causing Crigler-Najjar and Gilbert syndromes : correlation of genotype to phenotype", Hum Mutat, 16, pp.297~306 (2000)
25. Beutler E, "Racial variability in the UDPglucuronosyltransferase 1(UGT1A1)promoter : a balanced polymorphism for regulation of bilirubin metabolism?", Proc Natl Acad Sci U S A, 95, pp.8170~8174 (1998)
26. Maruo Y, "Association of neonatal hyperbilirubinemia with bilirubin UDP-glucuronosyltransferase polymorphism", Pediatrics, 103(6 Pt 1), pp.1224~1227 (1999)
27. Ko JS, "Molecular analysis of the UGT1A1 gene in Korean patients with Crigler-Najjar syndrome type II", Pediatr Gastroenterol Hepatol Nutr, 17, pp.37~40 (2014)
28. Lee JM, "The relationship between Gly71Arg and TATA box polymorphism of UGT1A1 gene and prolonged hyperbilirubinemia of breast milk feeding infant in Korean", Korean J Pediatr, 51, pp.150~155 (2008)
29. Kang H, "The association of neonatal hyperbilirubinemia with UGT1A1 and CYP1A2 gene polymorphism in Korean neonates", Korean J Pediatr, 48, pp.380~386 (2005)
30. Kim JY, "1828G > A polymorphism of the UDP-glucuronosyltransferase gene(UGT1A1)for neonatal hyperbilirubinemia in Koreans", Korean J Pediatr, 49, pp.34~39 (2006)
31. Kim JJ, "Genetic spectrum of UGT1A1 in Korean patients with unconjugated hyperbilirubinemia", Ann Lab Med, 40, pp.281~283 (2020)
32. Nguyen TT, "The relationship between hyperbilirubinemia and the promoter region and first exon of UGT1A1 gene polymorphisms in Vietnamese newborns", Pediatr Res, 88, pp.940~944 (2020)
33. Maruo Y, "Genotype of UGT1A1 and phenotype correlation between Crigler-Najjar syndrome type II and Gilbert syndrome", J Gastroenterol Hepatol, 31, pp.403~408 (2016)
34. Wu XJ, "UGT1A1 gene mutations and neonatal hyperbilirubinemia in Guangxi Heiyi Zhuang and Han populations", Pediatr Res, 78, pp.585~588 (2015)
35. Sato H, "The genetic basis of Gilbert’s syndrome", Lancet, 347, pp.557~558 (1996)
36. Liu JY, "Distribution of the UGT1A1*28 polymorphism in Caucasian and Asian populations in the US : a genomic analysis of 138 healthy individuals", Anticancer Drugs, 18, pp.693~696 (2007)
37. Preer GL, "Understanding and managing breast milk jaundice", Arch Dis Child Fetal Neonatal Ed, 96, pp.F461~F466 (2011)
38. Soldi A, "Neonatal jaundice and human milk", J Matern Fetal Neonatal Med, 24(Suppl 1), pp.85~87 (2011)
39. Maruo Y, "Prolonged unconjugated hyperbilirubinemia associated with breast milk and mutations of the bilirubin uridine diphosphate-glucuronosyltransferase gene", Pediatrics, 106, pp.E59~ (2000)
40. Yang Z, "UGT1A1*6mutation associated with the occurrence and severity in infants with prolonged jaundice", Front Pediatr, 10, pp.1080212~ (2022)
41. Alaee E, "The association between prolonged jaundice and UGT1A1 gene polymorphism(G71R)in Gilbert’s syndrome", J Clin Diagn Res, 10, pp.GC05~GC08 (2016)
42. Yamamoto K, "Contribution of two missense mutations(G71R and Y486D)of the bilirubin UDP glycosyltransferase(UGT1A1)gene to phenotypes of Gilbert’s syndrome and Crigler-Najjar syndrome type II", Biochim Biophys Acta, 1406, pp.267~273 (1998)
43. Arias IM, "Chronic nonhemolytic unconjugated hyperbilirubinemia with glucuronyl transferase deficiency : clinical, biochemical, pharmacologic and genetic evidence for heterogeneity", Am J Med, 47, pp.395~409 (1969)
44. Abuduxikuer K, "UGT1A1genotypes and unconjugated hyperbilirubinemia phenotypes in post-neonatal Chinese children : a retrospective analysis and quantitative correlation", Medicine(Baltimore), 97, pp.e13576~ (2018)
45. Satrom KM, "Liver disease in children", pp.182~203 (2021), Cambridge University Press
46. Takano M, "UGT1A1 polymorphisms in cancer : impact on irinotecan treatment", Pharmgenomics Pers Med, 10, pp.61~68 (2017)
47. Iyer L, "Genetic predisposition to the metabolism of irinotecan(CPT-11) : role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite(SN-38)in human liver microsomes", J Clin Invest, 101, pp.847~854 (1998)
48. Burchell B, "Drug-mediated toxicity caused by genetic deficiency of UDPglucuronosyltransferases", Toxicol Lett, 112-113, pp.333~340 (2000)
49. Lankisch TO, "Gilbert’s disease and atazanavir : from phenotype to UDP-glucuronosyltransferase haplotype", Hepatology, 44, pp.1324~1332 (2006)
50. Deterding K, "Gilbert’s syndrome and antiviral therapy of hepatitis C", Ann Hepatol, 8, pp.246~250 (2009)
51. Xu CF, "Pazopanib-induced hyperbilirubinemia is associated with Gilbert’s syndrome UGT1A1 polymorphism", Br J Cancer, 102, pp.1371~1377 (2010)
52. Bale G, "Incidence and risk of gallstone disease in Gilbert’s syndrome patients in Indian population", J Clin Exp Hepatol, 8, pp.362~366 (2018)
53. Tsezou A, "Gilbert syndrome as a predisposing factor for cholelithiasis risk in the Greek adult population", Genet Test Mol Biomarkers, 13, pp.143~146 (2009)

관련 논문AI추천